Dr. Shrikant Karwa Foundation Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 30-07-2024
- Paid Up Capital ₹ 10.00 K
as on 30-07-2024
- Company Age 12 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 417.60%
(FY 2023)
- Profit -216.98%
(FY 2023)
- Ebitda -23675.17%
(FY 2023)
- Net Worth -122.26%
(FY 2023)
- Total Assets -76.78%
(FY 2023)
About Dr. Shrikant Karwa Foundation
The Corporate was formerly known as Nasik Maheshwari Shikshan Seva Samiti. The Company is engaged in the Education Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 10.00 K , as per Ministry of Corporate Affairs (MCA) records.
Shrikant Karwa, Santosh Jajoo, Anand Zawar, and Five other members serve as directors at the Company.
- CIN/LLPIN
U80210MH2012NPL231902
- Company No.
231902
- Company Classification
Private Not For Profit Company
- Incorporation Date
06 Jun 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dr. Shrikant Karwa Foundation?
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anand Zawar  | Director | 06-Jun-2012 | Current |
| Shrikant Karwa | Director | Current | |
| Santosh Jajoo | Director | 06-Jun-2012 | Current |
| Umesh Mundada | Director | 06-Jun-2012 | Current |
| Aruna Laddha | Director | 06-Jun-2012 | Current |
| Durgaprasad Jaju | Director | 03-Jul-2024 | Current |
Financial Performance of Dr. Shrikant Karwa Foundation.
Dr. Shrikant Karwa Foundation, for the financial year ended 2023, experienced significant growth in revenue, with a 417.6% increase. The company also saw a substantial fall in profitability, with a 216.98% decrease in profit. The company's net worth observed a substantial decline by a decrease of 122.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr. Shrikant Karwa Foundation?
In 2023, Dr. Shrikant Karwa Foundation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Catapro Pharmalab Private LimitedActive 1 year 7 monthsShrikant Karwa and Manju Karwa are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dr. Shrikant Karwa Foundation?
Unlock and access historical data on people associated with Dr. Shrikant Karwa Foundation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr. Shrikant Karwa Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Shrikant Karwa Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
